Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
ThreatLocker in Orlando, FL is seeking a Security Analyst LV.1 focused on endpoint protection. You will analyze logs, respond to alerts, classify threats, and provide detailed threat briefings to customers.
You will investigate using big data analytics, communicate findings clearly, manage ThreatLockerDetect incidents end-to-end, and stay current on emerging cyber threats.
If you are unable to complete this application due to a disability, contact this employer to ask for an accommodation or an alternative application process.
2 days ago Requisition ID: 1045
ThreatLocker® is a global cybersecurity leader that stops cyberattacks before they happen. The company’s Zero Trust Platform prevents breaches from both known and unknown threats by allowing only explicitly trusted software and activity across endpoints, networks, and cloud systems. Built to deploy quickly and scale across complex environments, the platform reduces operational overhead while keeping business running uninterrupted. Headquartered in Orlando, Florida, with offices in Dublin, Dubai, and Brisbane, ThreatLocker protects over 70,000 organizations worldwide.
As a Security Analyst specializing in endpoint protection, you will be essential in defending client and internal systems from evolving cyber threats.Duties involve log analysis in response to alerts, classifying suspicious activity, handling alert queues, and providing detailed threat briefings to affected customers.
The duties described below are representative of those encountered while performing the essential functions of this position. If necessary, reasonable accommodation may be requested and will be evaluated for its relationship to the essential functions that must be performed.
A background check and drug/substance screening are required after a conditional offer. Employment will proceed only upon receiving clear results from both.
ThreatLocker also conducts randomized drug and substance testing approximately every 60 days, in line with the same screening standards.